Home » Stocks » CDMO

Avid Bioservices, Inc. (CDMO)

Stock Price: $25.94 USD 0.34 (1.33%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
Market Cap 1.58B
Revenue (ttm) 95.87M
Net Income (ttm) 3.32M
Shares Out 60.84M
EPS (ttm) 0.06
PE Ratio 455.09
Forward PE 116.28
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $25.94
Previous Close $25.60
Change ($) 0.34
Change (%) 1.33%
Day's Open 25.59
Day's Range 25.20 - 26.55
Day's Volume 461,360
52-Week Range 6.49 - 27.02

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Former SVP of Global Manufacturing at Biogen Has Nearly 30 Years of Biopharmaceutical Industry Experience Former SVP of Global Manufacturing at Biogen Has Nearly 30 Years of Biopharmaceutical Industry E...

3 weeks ago - GlobeNewsWire

-- Recorded Fourth Quarter Revenue of $27.6 Million and Annual Revenue of $95.9 Million -- -- Achieved Four Consecutive Quarters of Operational Profitability During Fiscal 2021 --

Other stocks mentioned: CDMOP
3 weeks ago - GlobeNewsWire

TUSTIN, Calif., June 22, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives ...

Other stocks mentioned: CDMOP
1 month ago - GlobeNewsWire

Avid Bioservices (CDMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Other stocks mentioned: CDMOP
1 month ago - Zacks Investment Research

Investors in search of long-term growth are increasingly choosing biotech stocks like BNTX stock and MRNA stock for their portfolios. The post 7 A-Rated Biotech Stocks to Buy Now appeared first on Inves...

Other stocks mentioned: BNGO, BNTX, MRNA, VTGN
1 month ago - InvestorPlace

Avid Bioservices (CDMO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Other stocks mentioned: CDMOP
1 month ago - Zacks Investment Research

ZYNLONTA™ Recently Approved as First and Only CD19-Targeted Antibody Drug Conjugate for Single-Agent Treatment for Adult Patients with Relapsed or Refractory (r/r) Diffuse Large B-cell Lymphoma (DLBCL) ...

Other stocks mentioned: CDMOP
1 month ago - GlobeNewsWire

Small-cap stocks in the biotech space have been in a slump, but these seven companies could see big moves just around the corner. The post 7 Small-Cap Biotech Stocks to Watch for Upcoming Catalysts appe...

Other stocks mentioned: AGEN, ATOS, COCP, OCGN, SIGA, SIOX
2 months ago - InvestorPlace

As of late, it has definitely been a great time to be an investor in Avid Bioservices, Inc. (CDMO).

Other stocks mentioned: CDMOP
2 months ago - Zacks Investment Research

TUSTIN, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (the “company”), a dedicated biologics contract development and manufacturing organization (CDMO) working to impr...

Other stocks mentioned: CDMOP
3 months ago - GlobeNewsWire

Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Interactive Brokers (IBKR), Avid (CDMO), Oncternal (ONCT), Amtech (ASYS) and Aytu.

Other stocks mentioned: ASYS, AYTU, IBKR, ONCT
3 months ago - Zacks Investment Research

Find Strong Stocks to Start Q2 with New Analyst Coverage

Other stocks mentioned: IBKR, MP
3 months ago - Zacks Investment Research

Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like UFP Industries (UFPI), Interactive Brokers (IBKR), Avid (CDMO), Amtech (ASYS) and GAIA

Other stocks mentioned: ASYS, GAIA, IBKR, UFPI
4 months ago - Zacks Investment Research

TUSTIN, Calif., March 17, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improv...

Other stocks mentioned: CDMOP
4 months ago - GlobeNewsWire

Avid Bioservices (CDMO) has been struggling lately, but the selling pressure may be coming to an end soon

Other stocks mentioned: CDMOP
4 months ago - Zacks Investment Research

TUSTIN, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) (the “company”), a dedicated biologics contract development and manufacturing organization (CDMO) w...

Other stocks mentioned: CDMOP
4 months ago - GlobeNewsWire

Avid Bioservices (CDMO) delivered earnings and revenue surprises of 150.00% and 9.03%, respectively, for the quarter ended January 2021. Do the numbers hold clues to what lies ahead for the stock?

Other stocks mentioned: CDMOP
4 months ago - Zacks Investment Research

TUSTIN, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) (the “company”), a dedicated biologics contract development and manufacturing organization (CDMO) w...

Other stocks mentioned: CDMOP
4 months ago - GlobeNewsWire

Shares of Avid Bioservices (NASDAQ:CDMO) increased in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 116.67% over the past year to $0.01, which bea...

Other stocks mentioned: CDMOP
4 months ago - Benzinga

-- Third Quarter Revenue Increased 61% to $21.8 Million -- -- S igned $74 Million in New Orders to End the Quarter with a Backlog of $120 Million --

Other stocks mentioned: CDMOP
4 months ago - GlobeNewsWire

TUSTIN, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improv...

Other stocks mentioned: CDMOP
4 months ago - GlobeNewsWire

TUSTIN, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improv...

Other stocks mentioned: CDMOP
4 months ago - GlobeNewsWire

Keep in mind downside risk, if their respective candidates fail to pan out. But, there may be opportunity with these seven biotech stocks targeting treatments for long-haul Covid-19.

Other stocks mentioned: AIM, CYDY, FLGT, HGEN, JAGX, PRTC
5 months ago - InvestorPlace

Build Out of Myford Facility Will Expand Current Footprint to Include Second Manufacturing Train with Both Upstream and Downstream Processing Suites

Other stocks mentioned: CDMOP
5 months ago - GlobeNewsWire

BURLINGAME, Calif. & TUSTIN, Calif.--(BUSINESS WIRE)--Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) (“Avid”) and Humanigen, Inc. (NASDAQ:HGEN) (“Humanigen”) today announced that they have entered ...

Other stocks mentioned: CDMOP, HGEN
5 months ago - Business Wire

TUSTIN, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

Other stocks mentioned: CDMOP
7 months ago - GlobeNewsWire

TUSTIN, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

Other stocks mentioned: CDMOP
7 months ago - GlobeNewsWire

TUSTIN, Ca., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve pa...

Other stocks mentioned: CDMOP
7 months ago - GlobeNewsWire

TUSTIN, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

Other stocks mentioned: CDMOP
7 months ago - GlobeNewsWire

The company reported great fiscal 2021 Q2 results.

Other stocks mentioned: CDMOP
7 months ago - The Motley Fool

Avid Bioservices' (CDMO) CEO Nick Green on Q2 2021 Results - Earnings Call Transcript

Other stocks mentioned: CDMOP
7 months ago - Seeking Alpha

Shares of Avid Bioservices (NASDAQ:CDMO) moved higher by 8.2% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 133.33% over the past year to $0...

Other stocks mentioned: CDMOP
7 months ago - Benzinga

-- Recorded Second Quarter Revenue of $ 21 .1 Million -- -- Signed $28 Million in Business Orders and Ended the Quarter with a Backlog of $67 Million --

Other stocks mentioned: CDMOP
7 months ago - GlobeNewsWire

TUSTIN, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

Other stocks mentioned: CDMOP
7 months ago - GlobeNewsWire

TUSTIN, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

Other stocks mentioned: CDMOP
8 months ago - GlobeNewsWire

TUSTIN, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), today announced that it will hold its 2020 Annual Meeting of Stockholders (the “Annual Meeting”)...

Other stocks mentioned: CDMOP
10 months ago - GlobeNewsWire

TUSTIN, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to impr...

Other stocks mentioned: CDMOP
10 months ago - GlobeNewsWire

Avid Bioservices, Inc. (CDMO) CEO Nick Green on Q1 2021 Results - Earnings Call Transcript

Other stocks mentioned: CDMOP
10 months ago - Seeking Alpha

Shares of Avid Bioservices (NASDAQ:CDMO) rose 6.81% after the company reported Q1 results.

Other stocks mentioned: CDMOP
10 months ago - Benzinga

-- Recorded First Quarter Revenue of $25.4 Million -- -- S igned Three New Customers and Project Expansion Orders with Current Customers for $20 Million --

Other stocks mentioned: CDMOP
10 months ago - GlobeNewsWire

TUSTIN, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to impro...

Other stocks mentioned: CDMOP
10 months ago - GlobeNewsWire

TUSTIN, Calif., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to impro...

Other stocks mentioned: CDMOP
10 months ago - GlobeNewsWire

TUSTIN, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to impro...

Other stocks mentioned: CDMOP
10 months ago - GlobeNewsWire

TUSTIN, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to impro...

Other stocks mentioned: CDMOP
11 months ago - GlobeNewsWire

Argonaut’s Clinical Fill-Finish Capabilities to Complement Avid’s Upstream and Downstream Process Development and Biologics Manufacturing Services in Supporting Developers of Biologic Therapeutics Argon...

Other stocks mentioned: CDMOP
11 months ago - GlobeNewsWire

Avid Bioservices (CDMO) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Other stocks mentioned: CDMOP
1 year ago - Zacks Investment Research

The company still had significant production problems. But it also picked up a lot of new business in Q4.

Other stocks mentioned: CDMOP
1 year ago - The Motley Fool

Investors need to pay close attention to Avid Bioservices (CDMO) stock based on the movements in the options market lately.

Other stocks mentioned: CDMOP
1 year ago - Zacks Investment Research

Avid Bioservices, Inc. (CDMO) CEO Richard Hancock on Q4 2020 Results - Earnings Call Transcript

Other stocks mentioned: CDMOP
1 year ago - Seeking Alpha

-- Appointed Nicholas Green as President and Chief Executive Officer -- -- Recorded Fourth Quarter Revenue of $12.6 Million and Annual Revenue of $59.7 Million --

Other stocks mentioned: CDMOP
1 year ago - GlobeNewsWire

About CDMO

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides var... [Read more...]

Industry
Biotechnology
Founded
1981
CEO
Nicholas Green
Employees
252
Stock Exchange
NASDAQ
Ticker Symbol
CDMO
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for CDMO stock is "Strong Buy." The 12-month stock price forecast is 28.25, which is an increase of 8.91% from the latest price.

Price Target
$28.25
(8.91% upside)
Analyst Consensus: Strong Buy